 Home > Biochemistry News > Biotechnology News > New cutting-edge to improve the safety and durability of CAR-T therapy receives 250 million U.S. dollars from Blackstone

New cutting-edge to improve the safety and durability of CAR-T therapy receives 250 million U.S. dollars from Blackstone

 Last Update: 2022-01-12
 Source: Internet
 Author: User

Tags

reduce carboplatin side effects

nardil side effects

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On November 8, 2021, Autolus Therapeutics announced that it has reached a strategic cooperation and financing agreement with Blackstone Life Sciences

Obe-cel aims to overcome the limitations of current CAR-T cell therapy in terms of clinical activity and safety

In the trial data released in June this year, obe-cel achieved a 100% complete remission rate in a cohort of patients for the treatment of indolent B-cell non-Hodgkin's lymphoma (iNHL)

▲Obe-cel's performance in the treatment of ALL patients (picture source: Autolus official website)

Reference materials:

[1] Blackstone Life Sciences to invest up to $250 million in Autolus Therapeutics to develop obe-cel in adult Acute Lymphoblastic Leukemia (ALL) and advance broader platform.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.